Skip to main content
. 2020 Oct 23;10(4):188. doi: 10.3390/jpm10040188

Table 3.

Detected molecular alterations.

Genomic Alteration Absolute Numbers Frequency in %
TP53 228 19.9% MET 9 0.8% VA65:C90HL 4 0.3% RHOA 2 0.2%
KRAS 103 9.0% PTCH1 9 0.8% CCND1 3 0.3% ROS1 2 0.2%
PIK3CA 54 4.7% RAD50 9 0.8% CDH1 3 0.3% SF3B1 2 0.2%
PTEN 37 3.2% AKT1 8 0.7% DDR2 3 0.3% SRC 2 0.2%
APC 28 2.4% FGFR3 8 0.7% ESR1 3 0.3% TERT 2 0.2%
CDKN2A 28 2.4% SMARCB1 8 0.7% FGFR4 3 0.3% RHOA 2 0.2%
NOTCH1 26 2.3% BRCA1 7 0.6% HRAS 3 0.3% ROS1 2 0.2%
ATM 25 2.2% IDH2 7 0.6% MAP2K1 3 0.3% SF3B1 2 0.2%
SMAD4 19 1.7% MSH6 7 0.6% MYCL 3 0.3% AKT2 1 0.1%
IDH1 17 1.5% PALB2 7 0.6% NTRK1 3 0.3% AR 1 0.1%
PIK3R1 17 1.5% SMARCA4 7 0.6% PDGFRA 3 0.3% AXL 1 0.1%
CTNNB1 16 1.4% TSC1 7 0.6% RAD51B 3 0.3% CBL 1 0.1%
BRCA2 15 1.3% ALK 6 0.5% RNF43 3 0.3% CD274 1 0.1%
RB1 15 1.3% BAP1 6 0.5% CDK4 2 0.2% CDK4 1 0.1%
EGFR 14 1.2% FGFR2 6 0.5% CCND2 2 0.2% CHEK2 1 0.1%
FANCA 14 1.2% NBN 6 0.5% CDK2 2 0.2% FANCI 1 0.1%
POLE 14 1.2% NF2 6 0.5% CHEK1 2 0.2% IGF1R 1 0.1%
TSC2 14 1.2% SMO 6 0.5% ERBB3 2 0.2% JAK1 1 0.1%
ATR 13 1.1% CDK12 5 0.4% EZH2 2 0.2% JAK2 1 0.1%
BRAF 13 1.1% ERBB4 5 0.4% FANCD2 2 0.2% MAPK1 1 0.1%
NF1 13 1.1% FGFR1 5 0.4% FLT3 2 0.2% MCL1 1 0.1%
ARID1A 12 1.0% MLH1 5 0.4% GNAQ 2 0.2% MDM2 1 0.1%
CREBBP 12 1.0% PMS2 5 0.4% JAK3 2 0.2% MDM4 1 0.1%
KIT 12 1.0% PTPN11 5 0.4% MAF 2 0.2% MSH 1 0.1%
FBXW7 11 1.0% ABL1 4 0.3% MAX 2 0.2% NFE2L2 1 0.1%
RET 11 1.0% ATRX 4 0.3% MSH2 2 0.2% NTRK3 1 0.1%
SLX4 11 1.0% CCND3 4 0.3% mTOR 2 0.2% PPP2R1A 1 0.1%
STK11 11 1.0% ERBB2 4 0.3% MYCN 2 0.2% RICTOR 1 0.1%
NOTCH2 10 0.9% KDR 4 0.3% NTRK2 2 0.2% TET2 1 0.1%
NOTCH3 10 0.9% MRE11A 4 0.3% PDGFRB 2 0.2% UTR3 1 0.1%
SETD2 10 0.9% NRAS 4 0.3% PIK3CB 2 0.2% AKT2 1 0.1%
GNAS 9 0.8% RAD51D 4 0.3% RAD51C 2 0.2%